The pharmaceutical landscape is experiencing a shift with the arrival of GLP-1 delivery devices. These cutting-edge formulations offer a potential approach to providing glucagon-like peptide-1 drugs for individuals managing type 2 diabetes . Instead of injections , a convenient patch applied to the skin could provide a steady quantity of the med… Read More